{"id":135,"date":"2025-11-19T16:19:00","date_gmt":"2025-11-19T10:49:00","guid":{"rendered":"https:\/\/www.najao.com\/learn\/?p=135"},"modified":"2026-01-26T03:15:25","modified_gmt":"2026-01-25T21:45:25","slug":"theranostics","status":"publish","type":"post","link":"https:\/\/www.najao.com\/learn\/theranostics\/","title":{"rendered":"Theranostics: The Future of Integrated Diagnosis and Therapy"},"content":{"rendered":"\n<h2 class=\"wp-block-heading\">Seeing and treating disease in one step<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Imagine a future when your doctor can not only spot a disease hiding deep inside your body, but also send a treatment straight to that exact spot at the same time. This is as fascinating as a guided missile with a camera attached. That\u2019s the magic of theranostics, also known as theragnostics<strong><sup>1<\/sup><\/strong>. The term coined by John Funkhouser itself is a blend of \u201ctherapy\u201d and \u201cdiagnostics,\u201d and it lets doctors \u201csee what they treat, and treat what they see,\u201d all with remarkable precision<strong><sup>2<\/sup><\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Beyond the old playbook<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Traditional medicine often separates diagnosis from treatment. You first get a scan, followed by a therapy\u2014sometimes that is done using a blunt instrument, like chemotherapy, that can\u2019t differentiate between a healthy and a sick cell. Theranostics flips this on its head. It uses molecular imaging to find disease-specific biomarkers<strong><sup>3<\/sup><\/strong>. And upon finding them, the same or a similar molecule delivers the therapy. Its high precision ensures that only troublemakers are targeted, leaving the healthy tissues alone, resulting in highly effective treatments, fewer side effects, and the ability to check\u2014almost in real-time\u2014if the therapy is actually working<strong><sup>4,5<\/sup><\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How theranostics works<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">At the heart of theranostics is the hunt for a molecular marker that\u2019s rare on healthy cells, but abundant on diseased ones. Prior to this step, <a href=\"https:\/\/www.najao.com\/learn\/network-pharmacology\/\" target=\"_blank\" rel=\"noreferrer noopener\">network pharmacology<\/a> analysis, often using <a href=\"https:\/\/www.najao.com\/learn\/multi-omics\/\" target=\"_blank\" rel=\"noreferrer noopener\">multi-omics data<\/a>, can be applied to map the complex molecular pathways of the disease and systematically identify the most central and impactful target\u2014like this molecular marker\u2014to ensure maximum therapeutic effect with minimal resistance. Scientists design a \u201choming device\u201d like a peptide or antibody that latches onto this marker<strong><sup>6<\/sup><\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">For diagnosis, this device is paired with a tiny \u201cbeacon,\u201d often a radioactive tracer, that identifies the disease on a scan<strong><sup>7<\/sup><\/strong>. By noticing where the scan glows, your doctor knows exactly where the disease lives.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">After knowing the location of the disease, comes the therapy step. The same homing device is loaded with a therapeutic payload, maybe a radioactive atom or a drug, and sent back into your body, where it homes in on the same bullseye and delivers the payload right where it is needed<strong><sup>8<\/sup><\/strong>. And most importantly, the doctors can use imaging to watch the therapy in action and course-correct if needed.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Key advantages and benefits<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Tailored just for you<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Theranostics is what <a href=\"https:\/\/www.najao.com\/learn\/precision-medicine\/\" target=\"_blank\" rel=\"noreferrer noopener\">personalized medicine<\/a> needs the most. It enables doctors to match the treatment to the unique molecular fingerprint of your disease after a prior analysis of benefits and risk factors<strong><sup>9<\/sup><\/strong>. As a result, only those who are likely to benefit get therapy. This \u201cpatient stratification\u201d means non-responders avoid unnecessary treatments, and resources are used in a more efficient manner.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Pinpoint power, less collateral damage<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Given that theranostics can <a href=\"https:\/\/www.najao.com\/learn\/drug-delivery\/\" target=\"_blank\" rel=\"noreferrer noopener\">deliver the therapy<\/a> straight to the target, much higher doses can be delivered to diseased cells, without harming the healthy tissues. This means more effective treatment with far fewer side effects\u2014a huge improvement over conventional \u201ccarpet bombing\u201d approaches like radiation therapy for <a href=\"https:\/\/www.najao.com\/learn\/cancer-carcinogenesis\/\" target=\"_blank\" rel=\"noreferrer noopener\">cancer<\/a><strong><sup>8<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Early feedback, smarter decisions<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The integrated imaging in theranostics allows doctors to see the therapy and its consequences in action, without having to wait months to see if a treatment is working. If it isn\u2019t, the plan can change\u2014fast\u2014so you\u2019re not stuck with an ineffective therapy<strong><sup>10<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Identifying subtle metastases<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">In cancer theranostics, scans can find the main tumor, in addition to the tiny metastases hiding elsewhere in the body<strong><sup>11<\/sup><\/strong>. Such tiny things are hard to detect on a regular scan. So, in this way theranostics help doctors plan a more complete and effective treatment.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Overall, theranostics offer treatment with fewer side effects, more effective disease control, and the ability to adapt treatment quickly, allowing patients to feel better and get back to living their lives earlier.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Oncology leads the way in theranostics<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Cancer has been the proving ground for theranostics, and this is because many tumors display unique markers that make them perfect targets for this approach. Here are some real-world examples:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Thyroid cancer:<\/strong> For decades, doctors have used radioactive iodine to both find and destroy thyroid cancer cells<strong><sup>12<\/sup><\/strong>. A small dose lights up the cancer on a scan, while a bigger dose delivers the knockout punch.<\/li>\n\n\n\n<li><strong>Neuroendocrine tumors:<\/strong> These rare tumors often have somatostatin receptors. A scan with Gallium-68 DOTATATE shows where the tumors are after binding with those receptors. And if they light up, <a href=\"https:\/\/www.hopkinsmedicine.org\/radiology\/theranostics\" target=\"_blank\" rel=\"noreferrer noopener\">Lutetium-177 DOTATATE<\/a> delivers radiation therapy directly to those spots<strong><sup>13<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Prostate cancer:<\/strong> Most prostate cancers express a protein called PSMA. PET scans with radiolabeled PSMA tracers tell us the cancer\u2019s location, and then Lutetium-177 PSMA therapy can target and treat even widespread, resistant diseases<strong><sup>14<\/sup><\/strong>.<\/li>\n\n\n\n<li><strong>Non-Hodgkin lymphoma:<\/strong> Some therapies use antibodies tagged with both diagnostic and therapeutic radioisotopes to find and treat lymphoma cells that carry the CD20 marker<strong><sup>15<\/sup><\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Challenges and future directions<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">New targets, new frontiers<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Scientists are working tirelessly to find more unique biomarkers, especially for cancers and diseases that don\u2019t yet have a theranostic option. The more markers we find, the more diseases we can treat this way. The hope is to expand theranostics to other diseases\u2014maybe even heart disease, infections, or autoimmune conditions<strong><sup>16-18<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Better tools for the job<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">There\u2019s a push to develop new radioactive atoms, such as powerful alpha-emitters, and smarter delivery vehicles, including <a href=\"https:\/\/www.najao.com\/learn\/nanomedicine\/\" target=\"_blank\" rel=\"noreferrer noopener\">nanomedicines<\/a> and gene therapies, to further increase the precision and reduce the toxicity of theranostics<strong><sup>19<\/sup><\/strong>.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Personalized dosing<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">The high precision of theranostics allows the use of greater doses for more effective treatment; however the perfect dose varies from patient to patient. Thus, research is ongoing to optimize the dosing for improved personalization of theranostics<strong><sup>20<\/sup><\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">From lab to clinic\u2014for everyone<br>Critical challenges include manufacturing these complex agents, getting them to hospitals before they decay, and making them affordable. Also, work needs to be done in training doctors and building clinical guidelines for the benefit of more patients.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">The Bottom Line<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Theranostics is more than just a new tool\u2014it\u2019s a new way of thinking about healthcare in general. The unification of diagnosis and therapy delivers the dream of truly personalized, precise, and adaptive care. Although its present use case revolves around cancer care, it has the capacity to transform the entire landscape of how we find and fight disease.<\/p>\n\n\n\n<!--nextpage-->\n\n\n\n<h2 class=\"wp-block-heading\">FAQs<\/h2>\n\n\n\n<h4 class=\"wp-block-heading\">1. What are the common side effects of theranostics?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">While theranostics aims to minimize harm to healthy tissue, some common side effects can occur, often milder than conventional systemic therapies. These may include fatigue, nausea, dry mouth, and temporary changes in blood cell counts. Specific side effects depend on the agent and target organ.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">2. Who is eligible for theranostics treatment?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Eligibility is highly specific to the disease and the available theranostic agent. Generally, patients are selected based on the presence of specific molecular targets (identified via a diagnostic scan) on their disease cells. Often, it&#8217;s considered for advanced or metastatic diseases that have shown resistance to conventional treatments.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">3. How long does a theranostics treatment typically take?<\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">A theranostics treatment cycle usually involves an initial diagnostic scan (which takes a few hours), followed by a therapeutic infusion that can last from minutes to several hours. Patients may need to stay in a specialized facility for a short period after therapy due to radioactivity. The full treatment course typically involves multiple cycles spread over weeks or months.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Reference<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">1. Kalash, R. S., Lakshmanan, V. K., Cho, C. S., <em>et al<\/em>. (2016). Theranostics. In&nbsp;<em>Biomaterials nanoarchitectonics<\/em>&nbsp;(pp. 197-215). William Andrew Publishing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">2. Sandach, P., Fendler, W. P., &amp; Herrmann, K. (2019). Theranostics of solid tumors: renaissance of a longstanding concept.&nbsp;<em>best practice onkologie<\/em>,&nbsp;<em>14<\/em>, 526-534.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">3. Li, H., Gong, Q., &amp; Luo, K. (2024). Biomarker-driven molecular imaging probes in radiotherapy.&nbsp;<em>Theranostics<\/em>,&nbsp;<em>14<\/em>(10), 4127.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">4. Muthu, M. S., Leong, D. T., Mei, L., <em>et al<\/em>. (2014). Nanotheranostics\u02d7 application and further development of nanomedicine strategies for advanced theranostics.&nbsp;<em>Theranostics<\/em>,&nbsp;<em>4<\/em>(6), 660.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">5. Song, X., Wang, R., Gao, J., <em>et al<\/em>. (2022). Construction of a biotin-targeting drug delivery system and its near-infrared theranostic fluorescent probe for real-time image-guided therapy of lung cancer.&nbsp;<em>Chinese Chemical Letters<\/em>,&nbsp;<em>33<\/em>(3), 1567-1571.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">6. Nagarajan, Y., Chandrasekaran, N., &amp; Deepa Parvathi, V. (2025). Functionalized nanomaterials in pancreatic cancer theranostics and molecular imaging.&nbsp;<em>ChemistryOpen<\/em>,&nbsp;<em>14<\/em>(1), e202400232.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">7. Kaur, C. D., Mishra, K. K., Sahu, A., <em>et al<\/em>. (2020). Theranostics: New era in nuclear medicine and radiopharmaceuticals. In&nbsp;<em>Medical isotopes<\/em>. IntechOpen.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">8. Svenson, S. (2013). Theranostics: are we there yet?.&nbsp;<em>Molecular pharmaceutics<\/em>,&nbsp;<em>10<\/em>(3), 848-856.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">9. Bhujwalla, Z. M., Kakkad, S., Chen, Z., <em>et al<\/em>. (2018). Theranostics and metabolotheranostics for precision medicine in oncology.&nbsp;<em>Journal of magnetic resonance<\/em>,&nbsp;<em>291<\/em>, 141-151.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">10. Turner, J. H. (2024). Theranostics: Timing is everything.&nbsp;<em>Cancer Biotherapy &amp; Radiopharmaceuticals<\/em>,&nbsp;<em>39<\/em>(9), 611-618.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">11. Dhandapani, R., Sethuraman, S., &amp; Subramanian, A. (2019). Nanohybrids\u2013cancer theranostics for tiny tumor clusters.&nbsp;<em>Journal of Controlled Release<\/em>,&nbsp;<em>299<\/em>, 21-30.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">12. Choudhury, P. S., &amp; Gupta, M. (2018). Differentiated thyroid cancer theranostics: radioiodine and beyond.&nbsp;<em>The British journal of radiology<\/em>,&nbsp;<em>91<\/em>(1091), 20180136.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">13. Sheikhbahaei, S., Sadaghiani, M. S., Rowe, S. P., <em>et al<\/em>. (2021). Neuroendocrine tumor theranostics: an update and emerging applications in clinical practice.&nbsp;<em>American Journal of Roentgenology<\/em>,&nbsp;<em>217<\/em>(2), 495-506.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">14. Iravani, A., Violet, J., Azad, A., <em>et al<\/em>. (2020). Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies.&nbsp;<em>Prostate cancer and prostatic diseases<\/em>,&nbsp;<em>23<\/em>(1), 38-52.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">15. Krasniqi, A., D&#8217;Huyvetter, M., Xavier, C., <em>et al<\/em>. (2017). Theranostic radiolabeled anti-CD20 sdAb for targeted radionuclide therapy of non-Hodgkin lymphoma.&nbsp;<em>Molecular cancer therapeutics<\/em>,&nbsp;<em>16<\/em>(12), 2828-2839.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">16. Wu, Y., Vazquez-Prada, K. X., Liu, Y., <em>et al<\/em>. (2021). Recent advances in the development of theranostic nanoparticles for cardiovascular diseases.&nbsp;<em>Nanotheranostics<\/em>,&nbsp;<em>5<\/em>(4), 499.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">17. Liu, H., Zhong, W., Zhang, X., <em>et al<\/em>. (2021). Nanomedicine as a promising strategy for the theranostics of infectious diseases.&nbsp;<em>Journal of Materials Chemistry B<\/em>,&nbsp;<em>9<\/em>(38), 7878-7908.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">18. Nag, S., Mitra, O., Tripathi, G., <em>et al<\/em>. (2023). Exploring the theranostic potentials of miRNA and epigenetic networks in autoimmune diseases: A comprehensive review.&nbsp;<em>Immunity, inflammation and disease<\/em>,&nbsp;<em>11<\/em>(12), e1121.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">19. Kr\u00f3licki, L., &amp; Kunikowska, J. (2022). Theranostics\u2013present and future.&nbsp;<em>Bio-Algorithms and Med-Systems<\/em>,&nbsp;<em>17<\/em>(4), 213-220.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">20. Ryu, J. H., Lee, S., Son, S., <em>et al<\/em>. (2014). Theranostic nanoparticles for future personalized medicine.&nbsp;<em>Journal of controlled release<\/em>,&nbsp;<em>190<\/em>, 477-484.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Traditional medicine often separates diagnosis from treatment. Theranostics flips this on its head. It uses molecular imaging to find disease-specific biomarkers. And upon finding them, the same or a similar molecule delivers the therapy with high precision and fewer side effects, and can check almost in real-time if the therapy is actually working.<\/p>\n","protected":false},"author":3,"featured_media":136,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,7],"tags":[],"coauthors":[10],"class_list":["post-135","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-healthcare","category-nanotechnology"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Theranostics: The Future of Integrated Diagnosis and Therapy<\/title>\n<meta name=\"description\" content=\"Theranostics unifies diagnosis and therapy to deliver truly personalized, precise, and adaptive care, transforming how we find and fight disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.najao.com\/learn\/theranostics\/\" \/>\n<link rel=\"next\" href=\"https:\/\/www.najao.com\/learn\/theranostics\/2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theranostics: The Future of Integrated Diagnosis and Therapy\" \/>\n<meta property=\"og:description\" content=\"Theranostics unifies diagnosis and therapy to deliver truly personalized, precise, and adaptive care, transforming how we find and fight disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.najao.com\/learn\/theranostics\/\" \/>\n<meta property=\"og:site_name\" content=\"Najao Inovix\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/najaoinovix\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-19T10:49:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-25T21:45:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/06\/Theranostics.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"682\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Sujay Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@najaoinovix\" \/>\n<meta name=\"twitter:site\" content=\"@najaoinovix\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Sujay Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/\"},\"author\":{\"name\":\"Sujay Ghosh\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/person\\\/dce56c4224dfcacff6edf2e58f0f68d2\"},\"headline\":\"Theranostics: The Future of Integrated Diagnosis and Therapy\",\"datePublished\":\"2025-11-19T10:49:00+00:00\",\"dateModified\":\"2026-01-25T21:45:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/\"},\"wordCount\":1684,\"publisher\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Theranostics.jpg\",\"articleSection\":[\"Healthcare\",\"Nanotechnology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/\",\"name\":\"Theranostics: The Future of Integrated Diagnosis and Therapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Theranostics.jpg\",\"datePublished\":\"2025-11-19T10:49:00+00:00\",\"dateModified\":\"2026-01-25T21:45:25+00:00\",\"description\":\"Theranostics unifies diagnosis and therapy to deliver truly personalized, precise, and adaptive care, transforming how we find and fight disease.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/theranostics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Theranostics.jpg\",\"contentUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/Theranostics.jpg\",\"width\":1024,\"height\":682,\"caption\":\"Theranostics\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#website\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/\",\"name\":\"Najao Inovix\",\"description\":\"Cooperation for Success\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#organization\",\"name\":\"Najao Inovix\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Najao-Favicon.png\",\"contentUrl\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/wp-content\\\/uploads\\\/2025\\\/05\\\/Najao-Favicon.png\",\"width\":2490,\"height\":2490,\"caption\":\"Najao Inovix\"},\"image\":{\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/najaoinovix\\\/\",\"https:\\\/\\\/x.com\\\/najaoinovix\",\"https:\\\/\\\/www.instagram.com\\\/najaoinovix\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/najao\\\/\",\"https:\\\/\\\/www.threads.com\\\/@najaoinovix\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/#\\\/schema\\\/person\\\/dce56c4224dfcacff6edf2e58f0f68d2\",\"name\":\"Sujay Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g0181851cb7cff8a9fa8e05f03e21ab7b\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g\",\"caption\":\"Sujay Ghosh\"},\"url\":\"https:\\\/\\\/www.najao.com\\\/learn\\\/author\\\/sujay\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theranostics: The Future of Integrated Diagnosis and Therapy","description":"Theranostics unifies diagnosis and therapy to deliver truly personalized, precise, and adaptive care, transforming how we find and fight disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.najao.com\/learn\/theranostics\/","next":"https:\/\/www.najao.com\/learn\/theranostics\/2\/","og_locale":"en_US","og_type":"article","og_title":"Theranostics: The Future of Integrated Diagnosis and Therapy","og_description":"Theranostics unifies diagnosis and therapy to deliver truly personalized, precise, and adaptive care, transforming how we find and fight disease.","og_url":"https:\/\/www.najao.com\/learn\/theranostics\/","og_site_name":"Najao Inovix","article_publisher":"https:\/\/www.facebook.com\/najaoinovix\/","article_published_time":"2025-11-19T10:49:00+00:00","article_modified_time":"2026-01-25T21:45:25+00:00","og_image":[{"width":1024,"height":682,"url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/06\/Theranostics.jpg","type":"image\/jpeg"}],"author":"Sujay Ghosh","twitter_card":"summary_large_image","twitter_creator":"@najaoinovix","twitter_site":"@najaoinovix","twitter_misc":{"Written by":"Sujay Ghosh","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.najao.com\/learn\/theranostics\/#article","isPartOf":{"@id":"https:\/\/www.najao.com\/learn\/theranostics\/"},"author":{"name":"Sujay Ghosh","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/person\/dce56c4224dfcacff6edf2e58f0f68d2"},"headline":"Theranostics: The Future of Integrated Diagnosis and Therapy","datePublished":"2025-11-19T10:49:00+00:00","dateModified":"2026-01-25T21:45:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.najao.com\/learn\/theranostics\/"},"wordCount":1684,"publisher":{"@id":"https:\/\/www.najao.com\/learn\/#organization"},"image":{"@id":"https:\/\/www.najao.com\/learn\/theranostics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/06\/Theranostics.jpg","articleSection":["Healthcare","Nanotechnology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.najao.com\/learn\/theranostics\/","url":"https:\/\/www.najao.com\/learn\/theranostics\/","name":"Theranostics: The Future of Integrated Diagnosis and Therapy","isPartOf":{"@id":"https:\/\/www.najao.com\/learn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.najao.com\/learn\/theranostics\/#primaryimage"},"image":{"@id":"https:\/\/www.najao.com\/learn\/theranostics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/06\/Theranostics.jpg","datePublished":"2025-11-19T10:49:00+00:00","dateModified":"2026-01-25T21:45:25+00:00","description":"Theranostics unifies diagnosis and therapy to deliver truly personalized, precise, and adaptive care, transforming how we find and fight disease.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.najao.com\/learn\/theranostics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.najao.com\/learn\/theranostics\/#primaryimage","url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/06\/Theranostics.jpg","contentUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/06\/Theranostics.jpg","width":1024,"height":682,"caption":"Theranostics"},{"@type":"WebSite","@id":"https:\/\/www.najao.com\/learn\/#website","url":"https:\/\/www.najao.com\/learn\/","name":"Najao Inovix","description":"Cooperation for Success","publisher":{"@id":"https:\/\/www.najao.com\/learn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.najao.com\/learn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.najao.com\/learn\/#organization","name":"Najao Inovix","url":"https:\/\/www.najao.com\/learn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/logo\/image\/","url":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/05\/Najao-Favicon.png","contentUrl":"https:\/\/www.najao.com\/learn\/wp-content\/uploads\/2025\/05\/Najao-Favicon.png","width":2490,"height":2490,"caption":"Najao Inovix"},"image":{"@id":"https:\/\/www.najao.com\/learn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/najaoinovix\/","https:\/\/x.com\/najaoinovix","https:\/\/www.instagram.com\/najaoinovix\/","https:\/\/www.linkedin.com\/company\/najao\/","https:\/\/www.threads.com\/@najaoinovix"]},{"@type":"Person","@id":"https:\/\/www.najao.com\/learn\/#\/schema\/person\/dce56c4224dfcacff6edf2e58f0f68d2","name":"Sujay Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g0181851cb7cff8a9fa8e05f03e21ab7b","url":"https:\/\/secure.gravatar.com\/avatar\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/75020d47c7623402695f739d0e19add7e387d7645c2f867ea8bdd24f4d8e6f92?s=96&d=mm&r=g","caption":"Sujay Ghosh"},"url":"https:\/\/www.najao.com\/learn\/author\/sujay\/"}]}},"_links":{"self":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/comments?post=135"}],"version-history":[{"count":4,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/135\/revisions"}],"predecessor-version":[{"id":410,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/posts\/135\/revisions\/410"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/media\/136"}],"wp:attachment":[{"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/media?parent=135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/categories?post=135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/tags?post=135"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.najao.com\/learn\/wp-json\/wp\/v2\/coauthors?post=135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}